Great Diamond Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Great Diamond Partners's DGX Position: Q2 2024 in Review
Great Diamond Partners sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 1,572 shares — an estimated $209K sold.
Great Diamond Partners first reported a position in DGX in Q4 2019 and held it in 16 quarters. The position peaked at $367K in Q4 2021. 838 funds tracked by Wall St. Rank hold DGX as of Q2 2024.
- Great Diamond Partners reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
- Great Diamond Partners sold 1,572 Quest Diagnostics shares in Q2 2024, an estimated $209K.
- Great Diamond Partners first reported a position in Quest Diagnostics in Q4 2019 and held it in 16 quarters.
- Great Diamond Partners's Quest Diagnostics position peaked at $367K in Q4 2021.
- 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.
Based on Great Diamond Partners's 13F filing for Q2 2024, filed 29 Jul 2024.